Sac-TMT Combined With Fruquintinib as Second-Line Treatment in Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Conditions
- Gastric Adenocarcinoma
- Gastroesophageal Junction (GEJ) Adenocarcinoma
- Gastro-esophageal Junction Adenocarcinoma
Interventions
- DRUG: Sacituzumab Tirumotecan + Fruquintinib
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Collaborators